Sai生命科学设定了IPO的价格,目的是为全球药物服务筹集3,043卢比。 Sai Life Sciences sets IPO price, aiming to raise up to Rs 3,043 crore for global drug services.

Sai生命科学公司在TPG Capital的支持下,为3 043卢比的作物供货设定了IPO价格等级,即每股522-549卢比。 Sai Life Sciences, backed by TPG Capital, has set an IPO price band of Rs 522-549 per share for a Rs 3,043 crore offering. 首次公开募股将于12月11日开放, 首次公开募股将包括价值高达9.5亿卢比的新发行, The IPO opens December 11, combining a fresh issue worth up to Rs 950 crore and an Offer For Sale of up to 3.81 crore shares by shareholders. 收益将用于偿还债务和一般公司用途。 Proceeds will be used for debt repayment and general corporate purposes. Sai生命科学向全球生物技术和制药公司提供药物发现和制造服务。 Sai Life Sciences provides drug discovery and manufacturing services to biotech and pharmaceutical firms globally.